Cocrystal Pharma COCP
NASDAQ COCP
$1.15 -0.02 (-1.72%)
As of: Aug 21, 2026 · 3:59 PM EDT

Cocrystal Pharma (COCP) Net Margin (2010 - 2026)

Cocrystal Pharma (COCP) posted Net Margin of 1037.33% for Q1 2026, down 249.89% sequentially from 296.47% in Q4 2020.

Cocrystal Pharma (COCP) Net Margin (2010 - 2026) Analysis & Trends

Cocrystal Pharma has reported Net Margin for 8 years, with the latest figure at 1037.33% in Q1 2026.

  • Quarterly Net Margin changed N/A year-over-year to 1037.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 525.31% (changed N/A YoY) and the FY2020 annual result came in at 479.05%, up 25479.0% from the prior year.
  • Net Margin fell to 1037.33% in Q1 2026 per COCP's latest filing, from 296.47% in the prior quarter.
  • Over five years, Net Margin peaked at 1037.33% in Q1 2026 and troughed at 1037.33% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 30.23%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 31.16%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -539.31%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 12.74%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.51%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -3.12%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 12.09%
10 Cocrystal Pharma 15.65 Mn 13.33 Mn - -3,022.86%

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,474.29%
Mar 31, 2026 -1,037.33%
Dec 31, 2020 -296.47%
Sep 30, 2020 -572.60%
Jun 30, 2020 -749.64%
Mar 31, 2020 -590.02%
Dec 31, 2019 -11,901.74%
Sep 30, 2019 -361.79%
Jun 30, 2019 -255.91%
Mar 31, 2019 58.51%
Sep 30, 2015 -2,550.00%
Jun 30, 2015 -9,329.63%
Mar 31, 2015 -108,618.52%
Jun 30, 2013 -37.31%
Mar 31, 2013 -72.74%
Dec 31, 2012 -11.29%
Sep 30, 2012 0.49%
Jun 30, 2012 -14.54%
Mar 31, 2012 -103.87%
Dec 31, 2011 -50.25%